<DOC>
	<DOCNO>NCT01207973</DOCNO>
	<brief_summary>The objective study investigate safety tolerability BI 113823 male female patient osteoarthritis , follow oral administration BI 113823 repeat rise dos .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics -Dynamics Multiple Rising Oral Doses BI 113823 Patients Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Inclusion criterion patient osteoarthritis Exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>